Compared to the controls, the tumor xenografts produced from MYLK-AS1 shRNA-expressing MHCC97-H cells were significantly inhibited, with smaller tumor volumes and lighter weights (Figure 6A). This evidence concerns the gene MYLK and neoplasm.